Literature DB >> 19096898

Imported fenproporex-based diet pills from Brazil: a report of two cases.

Pieter A Cohen1.   

Abstract

Banned amphetamine-based anorectics are illicitly imported into the United States (US), but little is known regarding the harm these diet pills pose to US residents. A 26-year-old woman using imported diet pills presented with a two-year history of intermittent chest pains, palpitations, headaches and insomnia. Urine toxicology screen detected amphetamines and benzodiazepines. Fenproporex and chlordiazepoxide were detected in her pills. Her symptoms resolved after she stopped using diet pills. A 38-year-old man using imported diet pills presented after his occupational urine screen was significantly positive for amphetamine. Fenproporex and fluoxetine were detected in his pills. These cases illustrate the potential harm from imported prescription diet pills that combine fenproporex with benzodiazepines, antidepressants, diuretics, laxatives and other substances. Increasing physicians' awareness of imported diet pill use may improve care of patients suffering from the pills' many adverse effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19096898      PMCID: PMC2642570          DOI: 10.1007/s11606-008-0878-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  17 in total

1.  Studies on the metabolism and toxicological detection of the amphetamine-like anorectic fenproporex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.

Authors:  T Kraemer; G A Theis; A A Weber; H H Maurer
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-01-28

2.  The pharmacovigilance of psychoactive medications in Brazil.

Authors:  Elisaldo Luiz de Araújo Carlini; Solange Aparecida Nappo
Journal:  Braz J Psychiatry       Date:  2004-01-15       Impact factor: 2.697

3.  Imported compounded diet pill use among Brazilian women immigrants in the United States.

Authors:  Pieter A Cohen; Danny McCormick; Carolyn Casey; Glen F Dawson; Karen A Hacker
Journal:  J Immigr Minor Health       Date:  2007-12-09

4.  [Subarachnoid hemorrhage caused by fenproporex consumption].

Authors:  V Bertol; J R Ara; A Oliveros; A I Gutiérrez
Journal:  Neurologia       Date:  1991 Aug-Sep       Impact factor: 3.109

5.  Scleroderma after therapy with appetite suppressants. Report on four cases.

Authors:  A Aeschlimann; P de Truchis; M F Kahn
Journal:  Scand J Rheumatol       Date:  1990       Impact factor: 3.641

6.  Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

Authors:  J L Nortier; M C Martinez; H H Schmeiser; V M Arlt; C A Bieler; M Petein; M F Depierreux; L De Pauw; D Abramowicz; P Vereerstraeten; J L Vanherweghem
Journal:  N Engl J Med       Date:  2000-06-08       Impact factor: 91.245

7.  Amphetamine lacing of an Internet-marketed neutraceutical.

Authors:  Minh H Nguyen; Tom Ormiston; Sanjay Kurani; Denise K Woo
Journal:  Mayo Clin Proc       Date:  2006-12       Impact factor: 7.616

8.  Inappropriate prescribing of compounded antiobesity formulas in Brazil.

Authors:  S A Nappo; E M de Oliveira; S Morosini
Journal:  Pharmacoepidemiol Drug Saf       Date:  1998-05       Impact factor: 2.890

9.  Use of anorectic amphetamine-like drugs by Brazilian women.

Authors:  Solange A Nappo; Ricardo Tabach; Ana Regina Noto; José Carlos F Galduróz; Elisaldo Araújo Carlini
Journal:  Eat Behav       Date:  2002

10.  [Iatrogenic hyperthyroidism. Report of an outbreak].

Authors:  A Goday; A Recasens; M Méndez; V Yetano; P Guirado
Journal:  Med Clin (Barc)       Date:  1995-11-18       Impact factor: 1.725

View more
  8 in total

1.  Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.

Authors:  Gislaine T Rezin; Camila B Furlanetto; Giselli Scaini; Samira S Valvassori; Cinara L Gonçalves; Gabriela K Ferreira; Isabela C Jeremias; Wilson R Resende; Mariane R Cardoso; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-15       Impact factor: 5.590

2.  The return of rainbow diet pills.

Authors:  Pieter A Cohen; Alberto Goday; John P Swann
Journal:  Am J Public Health       Date:  2012-07-19       Impact factor: 9.308

3.  Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States.

Authors:  Pieter A Cohen; Carly Benner; Danny McCormick
Journal:  J Gen Intern Med       Date:  2011-08-16       Impact factor: 5.128

4.  Effects of chronic administration of fenproporex on cognitive and non-cognitive behaviors.

Authors:  Cinara L Gonçalves; Camila B Furlanetto; Samira S Valvassori; Daniela V Bavaresco; Roger B Varela; Josiane Budni; João Quevedo; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-09-14       Impact factor: 3.584

5.  Effects of acute and chronic administration of fenproporex on DNA damage parameters in young and adult rats.

Authors:  Cinara L Gonçalves; Gislaine T Rezin; Gabriela K Ferreira; Isabela C Jeremias; Mariane R Cardoso; Samira S Valvassori; Bruna J P Munhoz; Gabriela D Borges; Bruno N Bristot; Daniela D Leffa; Vanessa M Andrade; João Quevedo; Emilio L Streck
Journal:  Mol Cell Biochem       Date:  2013-05-01       Impact factor: 3.396

6.  Illness appraisals and depression in the first year after HIV diagnosis.

Authors:  Judith Tedlie Moskowitz; Judith Wrubel; Jen R Hult; Stephanie Maurer; Michael Acree
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

Review 7.  Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets.

Authors:  Luiz H C Vasconcelos; Iara L L Souza; Lílian S Pinheiro; Bagnólia A Silva
Journal:  Front Pharmacol       Date:  2016-03-30       Impact factor: 5.810

Review 8.  Safety and efficacy of fenproporex for obesity treatment: a systematic review.

Authors:  Francisco José Roma Paumgartten; Sabrina Schaaf Teixeira Costa Pereira; Ana Cecilia Amado Xavier de Oliveira
Journal:  Rev Saude Publica       Date:  2016-05-24       Impact factor: 2.106

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.